Peer Engagement in Methamphetamine Harm-Reduction With Contingency Management (PEER-CM)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT05700994|
Recruitment Status : Not yet recruiting
First Posted : January 26, 2023
Last Update Posted : September 28, 2023
|Condition or disease||Intervention/treatment||Phase|
|Methamphetamine Abuse||Behavioral: Peer Contingency Management Behavioral: Standard of Care Contingency Management||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||1800 participants|
|Intervention Model:||Sequential Assignment|
|Intervention Model Description:||This is a cluster-randomized pragmatic trial using a hybrid type 1 effectiveness-implementation framework and stepped-wedge design.|
|Masking:||None (Open Label)|
|Primary Purpose:||Supportive Care|
|Official Title:||Peer Engagement in Methamphetamine Harm-Reduction With Contingency Management (PEER-CM)|
|Estimated Study Start Date :||November 1, 2023|
|Estimated Primary Completion Date :||June 30, 2025|
|Estimated Study Completion Date :||September 30, 2026|
Peer-facilitated contingency management (PEER-CM).
Behavioral: Peer Contingency Management
Participants allocated to peer-facilitated contingency management will receive incentives for achieving self-identified harm reduction goals set with peer specialists using a participant-driven harm reduction goal-setting process (e.g. completing overdose prevention and supply training, daily life goals, treatment and care goals, relationship and social support goals)
Other Name: PEER-CM
Active Comparator: Standard of Care
Standard of care contingency management.
Behavioral: Standard of Care Contingency Management
Participants allocated to standard of care contingency management will receive incentives for peer encounters.
Other Name: Standard of Care
- Number of participants who overdose [ Time Frame: 6 months from baseline ]Test the impact of incentives for achieving self-identified, personal harm reduction goals on the likelihood of overdose among people using methamphetamine at 6 months from enrollment identified through completed assessment.
- Number of participants who achieve self-identified goals [ Time Frame: 6 months from baseline ]Determine whether incentives for achieving self-identified, personal harm reduction goals increases engagement with harm reduction services at 6 months from enrollment identified through completed assessment.
- Number of participants who engage in substance use disorder treatment [ Time Frame: 6 months from baseline ]Determine whether incentives for achieving self-identified, personal harm reduction goals increases engagement with treatment services at 6 months from enrollment identified through completed assessment.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT05700994
|Contact: Todd Korthuis, MD, MPHemail@example.com|
|Contact: Sara McCrimmon, MPHfirstname.lastname@example.org|